These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11160856)

  • 1. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
    Schmidt K; Schrammel A; Koesling D; Mayer B
    Mol Pharmacol; 2001 Feb; 59(2):220-4. PubMed ID: 11160856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
    Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
    J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
    Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
    Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A; Müllershausen F; Smolenski A; Walter U; Schultz G; Koesling D
    Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
    Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
    Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.
    Nakane M; Hsieh G; Miller LN; Chang R; Terranova MA; Moreland RB; Kolasa T; Brioni JD
    Int J Impot Res; 2002 Apr; 14(2):121-7. PubMed ID: 11979328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.
    Berkan O; Bagcivan I; Kaya T; Yildirim K; Yildirim S; Doğan K
    Can J Physiol Pharmacol; 2007 May; 85(5):521-6. PubMed ID: 17632587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
    Friebe A; Koesling D
    Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
    Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
    Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
    Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
    Martin E; Lee YC; Murad F
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12938-42. PubMed ID: 11687640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition.
    Garthwaite G; Goodwin DA; Neale S; Riddall D; Garthwaite J
    Mol Pharmacol; 2002 Jan; 61(1):97-104. PubMed ID: 11752210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC; Garthwaite J
    Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of soluble guanylyl cyclase inhibits estradiol production and cyclic AMP accumulation from cultured rat granulosa cells.
    Tafoya MA; Chen JY; Stewart RL; Lapolt PS
    Fertil Steril; 2004 Oct; 82 Suppl 3():1154-9. PubMed ID: 15474089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.